Claris Lifesciences (Delisted) share news and announcements
BSE: 533288
Last traded ₹396.55 on 14 Mar 2018
Delisted on 22 Mar 2018.
Claris Lifesciences share news and announcements
337 announcements, routine notices left out, newest first. Page 5 of 7.
Mar 2014
18 Mar · Meeting
Feb 2014
Jan 2014
30 Jan · Claris receives for ANDA approval for Furosemide Injection in US
7 Jan · Dividend
Board of Directors of the Company at its meeting held on January 07, 2014 has fixed January 21, 2014 as Record Date for the purpose of ....7 Jan · Dividend
Board of Directors of the Company at its meeting held on January 07, 2014, inter alia, has transacted the following businesses: 1. ....2 Jan · Board meeting
Meeting of the Board of Directors of the Company will be held on January 07, 2014, inter alia, to consider, a proposal for (i) Buy Back of ....
Dec 2013
Nov 2013
Aug 2013
Jun 2013
6 Jun · Claris Lifesciences received ANDA approval for Levofloxacin Injection in the United States
May 2013
10 May · Board meeting
Board of Directors of the Company at its meeting held on May 10, 2013, inter alia, have considered and approved the resignation tendered ....10 May · Limited Review for March 31, 2013
2 May · Claris Lifesciences received ANDA approval for Metroprolol Tartrate Injection in the United States
Apr 2013
15 Apr · Change in Compliance Officer
Mr. Kirit Kanjaria has been appointed as Company Secretary and Compliance Officer of the Company in place of Mr. Rajesh Kumar Modi w.e.f. April 13, 2013.